As CEO of Pfizer, Albert Bourla emerged on the global stage during the COVID pandemic, leading the vaccine-maker to new heights while becoming a prominent voice for the scientific community. The years that followed have been more challenging.
The pharmaceutical giant has sought out new avenues of success with cancer-treatment drugs and to catch up with its competitors, which have dominated the market for weight-loss medications. Bourla spoke with TIME recently at his New York City HQ.You're turning 65 this year.
How many more years do you think you'll be leading Pfizer?Every December I take a glass of wine and then I reflect on how I was when I started the year, how I am as a personality, what have I learned, what have I changed in my life. I think that this? December I realize t…
المصدر: time
